BOXED WARNING LABAs increase the risk of asthma-related death; use only as additional therapy with a long-term asthma-control medication (e.g., inhaled corticosteroid) in patients not controlled on that alone.
FDA dosing
Population
Start
Target
Max
Asthma (with inhaled corticosteroid)
Adults and children ≥5 y
12 mcg (1 capsule) inhaled q12h
12 mcg q12h
24 mcg/day (1 capsule BID)
COPD maintenance
Adult
12 mcg (1 capsule) inhaled q12h
12 mcg q12h
24 mcg/day
Prevention of exercise-induced bronchospasm
Adults and children ≥5 y
12 mcg ≥15 min before exercise PRN
12 mcg PRN
one dose per 12 h
Renal Undefined
Hepatic Undefined
For EIB use, protection may last up to 12 hours; do not give additional doses within 12 hours.
Instructions
Oral inhalation only via AEROLIZER Inhaler; capsules must not be swallowed
Store capsules in blister; remove immediately before use
Do not exhale into the device
Do not exceed one capsule twice daily; more frequent use not recommended
For EIB, do not use additional doses within 12 hours
Contraindications
Treatment of asthma without concomitant long-term asthma-control medication (e.g., inhaled corticosteroid)
Cautions
Asthma-related death and asthma-related hospitalization (pediatric/adolescent)
Deterioration of disease/acute episodes; not for acute symptoms